September 14, 1999
Tenormin IV Recalled by AstraZenec
Cherry Hill, NJ (SafetyAlerts) - The Food and Drug
Administration (FDA) today reported that AstraZeneca, A Business Unit of Zeneca, Inc. is
recalling Tenormin IV because of current good manufacturing practice deviations (at
Tenormin IV (Atenolol) 5mg/10ml ampules, Rx used for
acute myocardial infarction. The product is shipped in cases of 60 ampules under the
Zeneca Pharmaceuticals label.NDC 0310-0108-10.
Recall #D-409-9. Class II
Lot Numbers: 3263B EXP 2/1/02, 3237B EXP 3/1/02, 3238B EXP 3/1/02, 3825A EXP
6/1/01, 3826A EXP 6/1/01, 3827A EXP 6/1/01, 3828A EXP 6/1/01, 3829A EXP 7/1/01, 4190A EXP
9/1/01, 4191A EXP 9/1/01, 4192A EXP 9/1/01, 8005A EXP 2/1/01, 8006A EXP 2/1/01, and 8014A
Marsam Pharmaceuticals, Inc., Cherry Hill, New Jersey.
AstraZeneca, A Business Unit of Zeneca, Inc., Wilmington, Delaware, by letter on
August 13, 1999. Firm-initiated recall ongoing.
Firm estimated that little product remained on market at time of recall initiation.
Safety Alerts compiles comprehensive safety
recall information for the United States. SafeMail is a free email service to warn
consumers of faulty products and contaminated foods. For complete information regarding
current recalls, past recalls and timely product warning notification visit: www.safetyalerts.com.